Aspirin in diabetic patients at primary prevention: insights of the VITAL cohort

PURPOSE: Aspirin use among patients with diabetes in primary prevention is still a matter of debate. We aimed to evaluate the potential cardiovascular risk benefit of aspirin in primary prevention, using data from a contemporary cohort. METHODS: Retrospective analysis of the VITAL cohort with > 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Caldeira, D., Alves, M., Ferreira, J. J., Pinto, F. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261209/
https://www.ncbi.nlm.nih.gov/pubmed/36652191
http://dx.doi.org/10.1007/s40618-022-02001-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261209/
https://www.ncbi.nlm.nih.gov/pubmed/36652191
http://dx.doi.org/10.1007/s40618-022-02001-3

Ejemplares similares